HIGH THROUGHPUT DNA PROFILING OF NEUROLOGICAL DISORDERS

Information

  • Research Project
  • 2273870
  • ApplicationId
    2273870
  • Core Project Number
    R43NS034589
  • Full Project Number
    1R43NS034589-01
  • Serial Number
    34589
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/8/1995 - 30 years ago
  • Project End Date
    5/31/1996 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    9/8/1995 - 30 years ago
  • Budget End Date
    5/31/1996 - 29 years ago
  • Fiscal Year
    1995
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/7/1995 - 30 years ago
Organizations

HIGH THROUGHPUT DNA PROFILING OF NEUROLOGICAL DISORDERS

DESCRIPTION (Adapted from applicant's abstract): Triplet repeat expansions of specific DNA loci have recently been shown to underlie ten neurological disorders, including Huntington's disease, fragile X syndrome, and myotonic dystrophy, and are suspected to be involved in several more. Polymerase chain reaction (PCR) based analysis of the number of repeats provides diagnostic information. There is a need to develop methodologies for automated, high- throughput DNA analysis for genetic typing of disease markers and for linkage analysis of undiscovered genes. This proposal describes development of integrated reagents and procedures to perform di-, tri-, and tetra-nucleotide repeat size typing of fluorescent PCR fragments by capillary array electrophoresis. The goal of Phase I is to optimize multiplex genetic typing protocols for a 96-capillary system and demonstrate typing of CA- repeat polymorphisms with 1,800 samples from families affected with hemochromatosis. The integrated methods, instrument, and software will have the capacity to analyze up to 5.5 million genotypes per year, increasing throughput by a factor of nine over current systems. The goals of Phase II are to validate the capillary array genetic analysis system for typing of Huntington's disease, fragile X syndrome and myotonic dystrophy, and test a proposed genotype-phenotype correlation of multiple sclerosis progression with repeat polymorphisms in the control region of the myelin basic protein gene.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R43
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    MOLECULAR DYNAMICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SUNNYVALE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94085
  • Organization District
    UNITED STATES